RR

Rogier Rooswinkel

General Partner at Forbion

Heemstede, North Holland

Overview 

Rogier Rooswinkel is a General Partner at Forbion, impacting the future of medicine through investments in Biotech and Health sectors. With a PhD (cum laude) from the Netherlands Cancer Institute and experience as a Postdoc, he has successfully invested in companies like Pheon Therapeutics and CatalYm, contributing to their growth and success.

Work Experience 

Forbion - Impacting the future of medicine

  • General Partner

    2013 - Current

Netherlands Cancer Institute

  • Postdoc

    2013 - 2013

  • PhD-student

    2008 - 2013

KlachtenCentrale

  • Owner

    2005 - 2007

Vm

VU medical Centre

  • Technician and programmer

    2003 - 2007

Education 

Investments 

Pheon Therapeutics

Series A

Total funding: $190M

Tessellate BIO

Seed

Total funding: $8M

CatalYm

Series C

Total funding: $200M

Amphista Therapeutics

Series B

Total funding: $61M

Articles About Rogier

Relevant Websites